Search Results - "Leung, Garret M.K."

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction by Li, Vivian W.K., Yim, Rita, Lee, Paul, Chin, Lynn, Au, Lester, Leung, Garret M.K., Sim, Joycelyn, Lie, Albert K.W., Tse, Eric, Kwong, Yok-Lam, Gill, Harinder

“…Relapse after allogeneic haematopoietic stem cell transplantation (HSCT) is one of the key determinants of outcome in myelofibrosis (MF) and remains an…”
Get full text

The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia by Gill, Harinder, Leung, Garret M. K., Lopes, David, Kwong, Yok‐Lam

Get full text

Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment by Gill, Harinder, Leung, Garret M. K., Seto, Wai-Kay, Kwong, Yok-Lam

Get full text

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3 by Zhang, Chunxiao, Lam, Stephen S. Y., Leung, Garret M. K., Tsui, Sze‐Pui, Yang, Ning, Ng, Nelson K. L., Ip, Ho‐Wan, Au, Chun‐Hang, Chan, Tsun‐Leung, Ma, Edmond S. K., Yip, Sze‐Fai, Lee, Harold K. K., Lau, June S. M., Luk, Tsan‐Hei, Li, Wa, Kwong, Yok‐Lam, Leung, Anskar Y. H.

“…Background Omacetaxine mepesuccinate (OME) has antileukemic effects against acute myeloid leukemia (AML) carrying an internal tandem duplication of Fms‐like…”
Get full text

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations by Leung, Garret M. K., Zhang, Chunxiao, Ng, Nelson K. L., Yang, Ning, Lam, Stephen S. Y., Au, Chun H., Chan, Tsun L., Ma, Edmond S. K., Tsui, Sze P., Ip, Ho W., So, Jason C. C., Ng, Margaret H. L., Cheng, Kelvin C. K., Wong, Kit F., Siu, Lisa L. P., Yip, Sze F., Lin, Shek Y., Lau, June S. M., Luk, Tsan H., Lee, Harold K. K., Lau, Chi K., Kho, Bonnie, Kwong, Yok L., Leung, Anskar Y. H.

“…The present study aimed to define a subtype of complex/monosomal karyotype (CK/MK) acute myeloid leukemia (AML) by its distinct clinical features, p53…”
Get full text

Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre by Leung, Garret M. K., Sim, Joycelyn P. Y., Hwang, Yu-Yan, Chan, Thomas S. Y., Lie, Albert K. W., Tse, Eric, Kwong, Yok-Lam

“…Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the…”
Get full text

Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis by Gill, Harinder, Ip, Ho-Wan, Yim, Rita, Tang, Wing-Fai, Pang, Herbert H., Lee, Paul, Leung, Garret M. K., Li, Jamilla, Tang, Karen, So, Jason C. C., Leung, Rock Y. Y., Li, Jun, Panagioutou, Gianni, Lam, Clarence C. K., Kwong, Yok-Lam

“…Current prognostication in myelofibrosis (MF) is based on clinicopathological features and mutations in a limited number of driver genes. The impact of other…”
Get full text

Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting by Gill, Harinder, Leung, Garret M.K., Yim, Rita, Lee, Paul, Pang, Herbert H., Ip, Ho-Wan, Leung, Rock Y.Y., Li, Jun, Panagiotou, Gianni, Ma, Edmond S.K., Kwong, Yok-Lam

“…Introduction: Real-world data of responses, quality-of-life (QOL) changes and adverse events in patients with myeloproliferative neoplasms (MPN) on…”
Get full text

Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group by Gill, Harinder, Leung, Garret M. K., Ooi, Melissa G. M., Teo, Winnie Z. Y., Wong, Chieh-Lee, Choi, Chul Won, Wong, Gee-Chuan, Lao, Zhentang, Rojnuckarin, Ponlapat, Castillo, Ma. Rosario Irene D., Xiao, Zhijian, Hou, Hsin-An, Kuo, Ming-Chung, Shih, Lee-Yung, Gan, Gin-Gin, Lin, Chien-Chin, Chng, Wee-Joo, Kwong, Yok-Lam

“…Myeloproliferative neoplasms (MPN) are a heterogeneous group of clonal hematopoietic stem cell disorders characterized clinically by the proliferation of one…”
Get full text

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation by Gill, Harinder, Yim, Rita, Pang, Herbert H., Lee, Paul, Chan, Thomas S. Y., Hwang, Yu‐Yan, Leung, Garret M. K., Ip, Ho‐Wan, Leung, Rock Y. Y., Yip, Sze‐Fai, Kho, Bonnie, Lee, Harold K. K., Mak, Vivien, Chan, Chi‐Chung, Lau, June S. M., Lau, Chi‐Kuen, Lin, Shek‐Yin, Wong, Raymond S. M., Li, Wa, Ma, Edmond S. K., Li, Jun, Panagiotou, Gianni, Sim, Joycelyn P. Y., Lie, Albert K. W., Kwong, Yok‐Lam

“…Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to…”
Get full text